None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (Experimental Group) 1. Adult men and women aged 19 to 60 years 2. Fatigue VAS score = 40 3. Individuals capable of normal communication 4. Individuals who have signed the informed consent form (Control Group) 1. Adult men and women matching the experimental group in gender and age 2. Fatigue VAS score < 40 3. Individuals capable of normal communication 4. Individuals who have signed the informed consent form
Exclusion criteria
Exclusion criteria: 1. Individuals with uncontrolled hypertension, edema, diabetes, or thyroid dysfunction 2. Individuals with tuberculosis, multiple sclerosis, or uncontrolled asthma 3. Individuals with major depressive disorder, bipolar disorder, schizophrenia, dementia, delusional disorder, claustrophobia, or panic disorder 4. Individuals with moderate or severe insomnia (PSQI = 15) 5. Individuals with a body mass index (BMI) less than 18.5 kg/m² or greater than 30 kg/m² 6. Pregnant or breastfeeding individuals 7. Individuals with a history of alcohol or substance abuse within the past three months 8. Individuals who have regularly consumed health supplements or products that may affect fatigue (such as health supplements or fatigue recovery products) within the past month 9. Heavy smokers (25 cigarettes/day or more) 10. Individuals with central nervous system damage, including stroke 11. Users of electronic devices worn inside the body, such as pacemakers 12. Users of life-supporting electronic medical devices, such as artificial heart-lung machines 13. Users of wearable electronic medical devices, such as ECG machines 14. Individuals with skin diseases (including trauma, bleeding, fractures, malignant tumors, eyelid, skull, oral and genital areas, or infectious diseases) 15. Individuals with photosensitivity or severe visual impairment (excluding those whose vision is corrected by lenses or who can write without glasses) 16. Any other individuals deemed unsuitable for participation by the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fatigue VAS;Fatigue Severity Scale (FSS);the modified Korean version of the Chalder Fatigue Scale(mKCFQ);pupillary response and eye movement | — |
Secondary
| Measure | Time frame |
|---|---|
| salivary cortisol;PSQI-K;vital sign;heart rate variety (HRV) | — |
Countries
Korea, Republic of
Contacts
Dongguk University Bundang Oriental Hospital